Chercheur qualifié FNRS
SSS/FASB -- Faculté de pharmacie et des sciences biomédicales
SSS/LDRI -- Louvain Drug Research Institute
|Year||Diploma Label||Educational Organization|
|2000||Licencié en sciences biomédicales (nutrition humaine)||Université catholique de Louvain|
|2005||Diplômé d'études approfondies en sciences de la santé||Université catholique de Louvain|
|2006||Docteur en sciences biomédicales||Université catholique de Louvain|
|1998||Graduat en Diététique||Institut Paul Lambin|
Dr. Patrice D. Cani is Professor at the Université catholique de Louvain (UCL), researcher from the FNRS, WELBIO investigator and group leader at the Louvain Drug Research Institute from the Université Catholique de Louvain (UCL), Brussels, Belgium.
He is visiting professor at the Imperial College London, UK, since 2010 and co-director of the European Associated Laboratory: “NeuroMicrobiota” (INSERM, Toulouse, France/UCL).
Prof. Cani is dietitian, earned a M.Sc. in Nutrition, a M.Sc. in Health Sciences and a PhD in Biomedical Sciences (2005).
Dr. Cani is and recipient of prestigious grants: ERC Starting Grant 2013 (ENIGMO), a PoC ERC grant 2015, the prize “Baillet Latour Grant for Medical Research 2015”, the International Prize of Physiology Lucien Dautrebande (2016).
He published more than 175 papers. He is member of several international associations; he is associate member of the Royal Academy of Medicine of Belgium, member of the Alumni College from the Royal Belgian Academy of Sciences and founding member of the Belgian Nutrition Society.
His motto is: "In Gut We Trust"
His main research interests are the investigation of interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes, cardiometabolic disorders and metabolic inflammation.
In 2007, he published the discovery of the concept of metabolic endotoxemia, and more recently, he discovered the beneficial role of the bacteria Akkermansia muciniphila on obesity and cardiometabolic risk factors (published in PNAS 2013 and Nature Medicine 2016).